STAT+: An AI tool aims to catch harder-to-detect heart attacks in EKGs
A newly approved AI tool can scan EKGs for severe heart attacks and, the company says, for rarer patterns indicating blocked arteries.
Read full article →Latest Healthcare Policy news from across the web.
A newly approved AI tool can scan EKGs for severe heart attacks and, the company says, for rarer patterns indicating blocked arteries.
Read full article →The back-to-back failures of cardiovascular drugs from Novartis and Novo Nordisk made headlines. They could also have a chilling effect across the industry.
Read full article →“Somewhere along the way, we forgot how to celebrate vaccines,” writes public health communications consultant Adam Zimmerman.
Read full article →“For thousands of families, the Sept. 11 attack did not end when the fires were extinguished. It simply changed form,” writes Raja Flores.
Read full article →The legal basis for the $500 checks, and who would get them, isn't entirely clear.
Read full article →Platinum chemotherapy aged the liver cells of treated children, making them look more like adult liver cells and possibly raising the long-term risk of new tumors
Read full article →This week on "The Readout LOUD" podcast: Two experimental drugs were heralded as the next era in heart disease treatment — why did they fail?
Read full article →There has been rancorous debate over doctors accepting free gifts and speaking fees from pharma companies. That doesn't mean doctors have reconsidered.
Read full article →Nominees for top federal health roles to face Congress, and Trump officials are betting on AI to help save rural health care.
Read full article →UniQure readout tests durability of benefits, an AI effort to manage heart failure, and more biotech news from The Readout
Read full article →A major Novartis shareholder has called for a shake-up of the drugmaker's board after its shares suffered a record fall following trial setbacks
Read full article →An ongoing shortage of cancer medications continues to force leading cancer centers around the U.S. to seek work-around strategies to treat patients and a majority also report that clinical trials…
Read full article →